These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21844228)

  • 1. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.
    Zhang Y; Romanov G; Bliska JB
    Infect Immun; 2011 Nov; 79(11):4322-31. PubMed ID: 21844228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
    Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
    Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sheppe AEF; Santelices J; Czyz DM; Edelmann MJ
    Microbiol Spectr; 2021 Sep; 9(1):e0049621. PubMed ID: 34319170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense.
    Zheng Y; Lilo S; Mena P; Bliska JB
    PLoS One; 2012; 7(4):e36019. PubMed ID: 22563435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ.
    Lilo S; Zheng Y; Bliska JB
    Infect Immun; 2008 Sep; 76(9):3911-23. PubMed ID: 18559430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
    Zheng Y; Lilo S; Brodsky IE; Zhang Y; Medzhitov R; Marcu KB; Bliska JB
    PLoS Pathog; 2011 Apr; 7(4):e1002026. PubMed ID: 21533069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence.
    Brodsky IE; Medzhitov R
    PLoS Pathog; 2008 May; 4(5):e1000067. PubMed ID: 18483548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death.
    Monack DM; Mecsas J; Ghori N; Falkow S
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10385-90. PubMed ID: 9294220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
    Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
    PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
    Auerbuch V; Golenbock DT; Isberg RR
    PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells.
    Fällman M; Andersson K; Håkansson S; Magnusson KE; Stendahl O; Wolf-Watz H
    Infect Immun; 1995 Aug; 63(8):3117-24. PubMed ID: 7622239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The virulence plasmid of Yersinia, an antihost genome.
    Cornelis GR; Boland A; Boyd AP; Geuijen C; Iriarte M; Neyt C; Sory MP; Stainier I
    Microbiol Mol Biol Rev; 1998 Dec; 62(4):1315-52. PubMed ID: 9841674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis.
    Harmon DE; Davis AJ; Castillo C; Mecsas J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3241-54. PubMed ID: 20498321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.
    Viboud GI; Bliska JB
    Annu Rev Microbiol; 2005; 59():69-89. PubMed ID: 15847602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.